English
Segment disclosures
Company overviewGINKGO BIOWORKS HOLDINGS, INC.
Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.
Revenue · Reported segment facts
8 dimension combinations 76 retained observations 18 reported periods
Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.
Operating Segments · Biosecurity Segment
Consolidation Items · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=dna:BiosecuritySegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-07-01 – 2023-09-30 | 18254000 | USD | 20231108 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 100145000 | USD | 20231108 | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 41719000 | USD | 20231108 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 289012000 | USD | 20231108 | Open filing evidence |
Operating Segments · Cell Engineering Segment
Consolidation Items · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=dna:CellEngineeringSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-07-01 – 2023-09-30 | 37176000 | USD | 20231108 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 116555000 | USD | 20231108 | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 24679000 | USD | 20231108 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 90409000 | USD | 20231108 | Open filing evidence |
Product · Biosecurity Segment
Product Or Service · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=us-gaap:ProductMember;us-gaap:StatementBusinessSegmentsAxis=dna:BiosecuritySegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2025-01-01 – 2025-12-31 | 0 | USD | 20260226 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 0 | USD | 20260226 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 28949000 | USD | 20260226 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 35455000 | USD | 20250225 | Open filing evidence |
Service · Biosecurity Segment
Product Or Service · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=us-gaap:ServiceMember;us-gaap:StatementBusinessSegmentsAxis=dna:BiosecuritySegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2025-01-01 – 2025-12-31 | 37409000 | USD | 20260226 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 53071000 | USD | 20260226 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 78975000 | USD | 20260226 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 298585000 | USD | 20250225 | Open filing evidence |
Biosecurity Segment
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=dna:BiosecuritySegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2025-07-01 – 2025-09-30 | 9457000 | USD | 20251106 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 30015000 | USD | 20251106 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 10470000 | USD | 20250807 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 20558000 | USD | 20250807 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 10088000 | USD | 20250506 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 13957000 | USD | 20251106 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 44013000 | USD | 20251106 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 20001000 | USD | 20250807 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 30056000 | USD | 20250807 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 10055000 | USD | 20250506 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 107924000 | USD | 20240229 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 18254000 | USD | 20241112 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 100145000 | USD | 20241112 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 35285000 | USD | 20240808 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 81891000 | USD | 20240808 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 46606000 | USD | 20240509 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 334040000 | USD | 20240229 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 200848000 | USD | 20240229 | Open filing evidence |
Cell Engineering And Biosecurity Segments
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=dna:CellEngineeringAndBiosecuritySegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-07-01 – 2024-09-30 | 89046000 | USD | 20241112 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 183196000 | USD | 20241112 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 56206000 | USD | 20240808 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 94150000 | USD | 20240808 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 37944000 | USD | 20240509 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 55430000 | USD | 20241112 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 216700000 | USD | 20241112 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 80568000 | USD | 20240808 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 161270000 | USD | 20240808 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 80702000 | USD | 20240509 | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 66398000 | USD | 20231108 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 379421000 | USD | 20231108 | Open filing evidence |
Cell Engineering Segment
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=dna:CellEngineeringSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2025-01-01 – 2025-12-31 | 132746000 | USD | 20260226 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 29380000 | USD | 20251106 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 106744000 | USD | 20251106 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 39134000 | USD | 20250807 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 77364000 | USD | 20250807 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 38230000 | USD | 20250506 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 173972000 | USD | 20260226 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 75089000 | USD | 20251106 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 139183000 | USD | 20251106 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 36205000 | USD | 20250807 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 64094000 | USD | 20250807 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 27889000 | USD | 20250506 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 143531000 | USD | 20260226 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 37176000 | USD | 20241112 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 116555000 | USD | 20241112 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 45283000 | USD | 20240808 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 79379000 | USD | 20240808 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 34096000 | USD | 20240509 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 143666000 | USD | 20250225 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 112989000 | USD | 20240229 | Open filing evidence |
Reportable Segment
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=dna:ReportableSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-07-01 – 2026-09-30 | 27711000 | USD | 20261109 | Open filing evidence |
| 2026-01-01 – 2026-09-30 | 67341000 | USD | 20261109 | Open filing evidence |
| 2026-04-01 – 2026-06-30 | 20156000 | USD | 20260806 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 39630000 | USD | 20260806 | Open filing evidence |
| 2026-01-01 – 2026-03-31 | 19474000 | USD | 20260507 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 29380000 | USD | 20261109 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 106744000 | USD | 20261109 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 39134000 | USD | 20260806 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 77364000 | USD | 20260806 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 38230000 | USD | 20260507 | Open filing evidence |